GGrantIndex
← Leaderboards

Centre/Aids Programme/Res/South Africa

Durban

Compare ↔
$63,271,788
Total funding
15
Grants

Funding over time

peak $6.8M · FY2010–25
$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$37,530,639 · 13
CDC$25,741,149 · 2

By mechanism

UM1$25,967,175 · 1
U2G$25,741,149 · 2
R01$9,185,521 · 6
UG1$773,000 · 1
R21$630,288 · 2
K43$616,095 · 1

Investigators at Centre/Aids Programme/Res/South Africa

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Anushka Naidoo$1,427,5121 gr2Sinaye Ngcapu$792,0981 gr3Aida Sivro$605,4781 gr

All-Time

Most funded here, all years

1Jo-Ann Shelley Passmore$3,179,0882 gr2Kogieleum Naidoo$2,620,7653 gr3Nigel Joel Garrett$2,048,9873 gr4Anushka Naidoo$1,427,5121 gr5Lyle McKinnon$1,094,1612 gr6Ayesha Bm Kharsany$852,4241 gr7Sinaye Ngcapu$792,0981 gr8Aida Sivro$605,4781 gr

Largest grants

CAPRISA AIDS TREATMENT PROGRAMME$5,400,429
U2G · FY2011 · PS
GH13-1335, S. AFRICA: REGIONAL CENTER FOR ADVANCED CLINICAL MANAGEMENT$4,000,000
U2G · FY2016 · GH
CAPRISA AIDS TREATMENT PROGRAMME$3,762,674
U2G · FY2012 · PS
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment$3,697,417
UM1 · FY2014 · AI
GH13-1335, S. AFRICA: REGIONAL CENTER FOR ADVANCED CLINICAL MANAGEMENT$3,250,000
U2G · FY2015 · GH
KwaZulu-Natal Clinical Trials Unit$3,060,050
UM1 · FY2021 · AI
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment$2,604,795
UM1 · FY2019 · AI
CAPRISA AIDS TREATMENT PROGRAMME$2,557,825
U2G · FY2010 · PS
CAPRISA AIDS TREATMENT PROGRAMME$2,557,825
U2G · FY2013 · PS
KwaZulu-Natal Clinical Trials Unit$2,132,207
UM1 · FY2022 · AI
KwaZulu-Natal Clinical Trials Unit$2,104,487
UM1 · FY2023 · AI
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment$2,053,782
UM1 · FY2020 · AI
KwaZulu-Natal Clinical Trials Unit$2,015,382
UM1 · FY2025 · AI
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment$1,906,882
UM1 · FY2017 · AI
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment$1,855,454
UM1 · FY2018 · AI
THE CAPRISA REGIONAL CENTER FOR ADVANCED CLINICAL MANAGEMENT$1,850,000
U2G · FY2014 · GH
KwaZulu-Natal Clinical Trials Unit$1,702,028
UM1 · FY2024 · AI
CAPRISA AIDS TREATMENT PROGRAMME$1,562,396
U2G · FY2013 · PS
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment$1,386,485
UM1 · FY2016 · AI
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment$1,160,092
UM1 · FY2015 · AI